Clinical Trials Browser

INDUSTRY × Neoplasms × etaracizumab × Clear all

NCT00263783 2009-01-29

Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors

Phase 1 Completed

Neoplasms

NCT00284817 2008-05-29

Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer

Phase 1/2 Completed

Neoplasms